Public annual accounts

Deltacel International financials

Name: Deltacel International financials
Creator: Upswitch
License: https://www.upswitch.app/terms-and-conditions

A multi-period view of the public annual-account figures reported for Deltacel International, with comparable measures and links to available source documents.

Company overview

Registry number

0880850268

Fiscal coverage

2024–2025

Public sources

cbso_bulk

Data updated

Jul 29, 2026

Financial evidence

Latest movements for Deltacel International

2025 versus 2024

Operating line: €80,400
EBITDA: €79,070
Total assets: €366,720
Equity: €161,873

EBITDA margin +98.3% · Equity ratio +44.1%

Multi-year filings

Filed annual accounts by fiscal year

Public regulator-filed figures across 2 years.

Source: NBB/CBSO

Fiscal year	Gross margin	EBITDA	Total assets	Equity	Filing
202531 Dec 2025	€80,400	€79,070	€366,720	€161,873	-
202431 Dec 2024	€5,116	€4,567	€278,476	€136,862	-

Gross margin line from gross margin (abbreviated schema). This is not reported turnover, so it is not used as a public valuation base.EBITDA basis: operating profit plus full add-backs.

Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.

Public company datasets

Explore the underlying reports

Valuation

2 valuation checkpoints · 2024 to 2025 · Method family

Open report

Fiscal year

Gross margin

EBITDA

Total assets

Equity

Filing

202531 Dec 2025

€80,400

€79,070

€366,720

€161,873

202431 Dec 2024

€5,116

€4,567

€278,476

€136,862